Description
CD64, clone MD22, is derived from fusion of P3X63Ag8 myeloma cells with splenocytes from BALB/c nu/nu mice immunized with FcγRI. CD45, clone 2D1, is derived from hybridization of mouse NS-1 myeloma cells with spleen cells from BALB/c mice immunized with human peripheral blood mononuclear cells (PBMCs). CD64 recognizes the 72-kilodalton (kd) human FcγRI glycoprotein that can bind monomeric IgG. CD45 (Anti-HLe-1) recognizes human leucocyte antigens, Mr 180 to 220 kd, that are members of the T200 family.
Preparation And Storage
The CD64/CD45 reagent is supplied as a combination of CD64 PE (≥95% 1:1 PE:mAb ratio) and CD45 PerCP in 1 mL of buffered saline with bovine serum albumin and 0.1% sodium azide. Vials should be stored at 2° to 8°C. QuantiBRITE reagents should not be frozen and should be protected from prolonged exposure to light. Each reagent is stable for the period shown on the bottle label when stored as directed.
| Description | Clone | Isotype | EntrezGene ID |
|---|---|---|---|
| N/A | N/A | | IgG1, κ,IgG2b, κ | N/A |
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Although not required, these products are manufactured in accordance with Good Manufacturing Practices.